These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8677799)

  • 1. Current status and future prospects of human gene therapy.
    Shimada T
    Acta Paediatr Jpn; 1996 Apr; 38(2):176-81. PubMed ID: 8677799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current status and future prospects of gene therapy].
    Ozawa K
    Nihon Ronen Igakkai Zasshi; 1999 Oct; 36(10):690-4. PubMed ID: 10614121
    [No Abstract]   [Full Text] [Related]  

  • 3. Gene therapy for severe combined immunodeficiency caused by adenosine deaminase deficiency: improved retroviral vectors for clinical trials.
    Onodera M; Nelson DM; Sakiyama Y; Candotti F; Blaese RM
    Acta Haematol; 1999; 101(2):89-96. PubMed ID: 10202239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. At age 2, gene therapy enters a growth phase.
    Thompson L
    Science; 1992 Oct; 258(5083):744-6. PubMed ID: 1472258
    [No Abstract]   [Full Text] [Related]  

  • 5. [Gene therapy for adenosine deaminase deficiency].
    Sakiyama Y
    Hokkaido Igaku Zasshi; 1996 Jan; 71(1):27-32. PubMed ID: 8727372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gene therapy for ADA deficiency].
    Ariga T; Sakiyama Y
    Tanpakushitsu Kakusan Koso; 1995 Dec; 40(17):2772-80. PubMed ID: 8584735
    [No Abstract]   [Full Text] [Related]  

  • 7. [Gene therapy of primary immunodeficiencies. Present and future].
    Serrano F; Laín de Lera T; González MA; García MJ; Abad JL; Bernad A
    Sangre (Barc); 1999 Apr; 44(2):143-53. PubMed ID: 10382324
    [No Abstract]   [Full Text] [Related]  

  • 8. Gene transfer into hematopoietic stem cells: prospects for human gene therapy.
    Einerhand MP; Valerio D
    Curr Top Microbiol Immunol; 1992; 177():217-35. PubMed ID: 1353431
    [No Abstract]   [Full Text] [Related]  

  • 9. Gene therapy.
    Verma IM
    Sci Am; 1990 Nov; 263(5):68-72, 81-4. PubMed ID: 2255890
    [No Abstract]   [Full Text] [Related]  

  • 10. [Gene therapy using retroviral vectors].
    Hanawa H; Shimada T
    Uirusu; 2003 Dec; 53(2):177-83. PubMed ID: 15071956
    [No Abstract]   [Full Text] [Related]  

  • 11. Retrovirus mediated gene transfer as therapy for adenosine deaminase (ADA) deficiency.
    Ramsey WJ; Mullen CA; Blaese RM
    Leukemia; 1995 Oct; 9 Suppl 1():S70. PubMed ID: 7475319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrovirus-mediated gene transfer in cancer therapy.
    Uckert W; Walther W
    Pharmacol Ther; 1994 Sep; 63(3):323-47. PubMed ID: 7530375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The current status of clinical gene therapy.
    Anderson WF
    Hum Gene Ther; 2002 Jul; 13(11):1261-2. PubMed ID: 12162809
    [No Abstract]   [Full Text] [Related]  

  • 14. Retroviral vectors containing putative internal ribosome entry sites: development of a polycistronic gene transfer system and applications to human gene therapy.
    Morgan RA; Couture L; Elroy-Stein O; Ragheb J; Moss B; Anderson WF
    Nucleic Acids Res; 1992 Mar; 20(6):1293-9. PubMed ID: 1313966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for retrovirus-based correction of severe, combined immunodeficiency (SCID).
    Fischer A; Hacein-Bey-Abina S; Cavazzana-Calvo M
    Methods Enzymol; 2012; 507():15-27. PubMed ID: 22365767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression vectors for human adenosine deaminase gene therapy.
    Moore KA; Fletcher FA; Alford RL; Villalon DK; Hawkins DH; MacGregor GR; Caskey CT; Belmont JW
    Genome; 1989; 31(2):832-9. PubMed ID: 2576653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of T lymphocyte-directed gene therapy for adenosine deaminase deficiency: long-term expression in vivo of genes introduced with a retroviral vector.
    Mullen CA; Snitzer K; Culver KW; Morgan RA; Anderson WF; Blaese RM
    Hum Gene Ther; 1996 Jun; 7(9):1123-9. PubMed ID: 8773514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retroviral-mediated gene transfer into mammalian cells.
    Kohn DB; Kantoff PW; Eglitis MA; McLachlin JR; Moen RC; Karson E; Zwiebel JA; Nienhuis A; Karlsson S; O'Reilly R
    Blood Cells; 1987; 13(1-2):285-98. PubMed ID: 3311223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy for inherited immunodeficiency.
    Touzot F; Hacein-Bey-Abina S; Fischer A; Cavazzana M
    Expert Opin Biol Ther; 2014 Jun; 14(6):789-98. PubMed ID: 24823313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Good Laboratory Practice Preclinical Safety Studies for GSK2696273 (MLV Vector-Based Ex Vivo Gene Therapy for Adenosine Deaminase Deficiency Severe Combined Immunodeficiency) in NSG Mice.
    Carriglio N; Klapwijk J; Hernandez RJ; Vezzoli M; Chanut F; Lowe R; Draghici E; Nord M; Albertini P; Cristofori P; Richards J; Staton H; Appleby J; Aiuti A; Sauer AV
    Hum Gene Ther Clin Dev; 2017 Mar; 28(1):17-27. PubMed ID: 28319446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.